Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schwerzmann

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Neurology|April 28, 2004
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacksM Schwerzmann, S Wiher, K Nedeltchev, et al.
Heart (British Cardiac Society)|July 20, 2007
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolismA Wahl, M Kunz, A Moschovitis, et al.
Heart (British Cardiac Society)|July 20, 2010
Cerebrovascular accidents in adult patients with congenital heart diseaseA Hoffmann, P Chockalingam, O H Balint, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Neurology|April 28, 2004
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacksM Schwerzmann, S Wiher, K Nedeltchev, et al.
Heart (British Cardiac Society)|July 20, 2007
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolismA Wahl, M Kunz, A Moschovitis, et al.
Heart (British Cardiac Society)|July 20, 2010
Cerebrovascular accidents in adult patients with congenital heart diseaseA Hoffmann, P Chockalingam, O H Balint, et al.
International Journal of Cardiology|July 17, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide studyH Yang, B J Bouma, K Dimopoulos, et al.
Pageof 2